Lafadofensine
Lafadofensine is the monoamines reuptake inhibitor. Lafadofensine has th sufficient effects after short-term administration (extracted from patent WO2006121218A1, compound 1) [1].
Product Specifications
CAS Number
[914989-90-5]
UNSPSC
12352005
Target
Monoamine Oxidase
Type
Reference compound
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/lafadofensine.html
Solubility
10 mM in DMSO
Smiles
FC(C=C1)=CC=C1N([C@H]2CCNC2)C3=CC=C(C=C3)F
Molecular Formula
C16H16F2N2
Molecular Weight
274.31
References & Citations
[1]Muneaki Kurimura, et al. N, n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors. Patent WO2006121218A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
214583-ML650 100 µL
CD152 (CTLA-4, Cytotoxic T-lymphocyte Protein 4) (MaxLight 650)
Ask
View Details 
MBS6402666-01 0.1 mL
SLC35F5 (Solute Carrier Family 35 Member F5, Hepatitis C Virus NS5A-transactivated Protein 3, HCV NS5A-transactivated Protein 3, NS5ATP3, UNQ2545/PRO6097) (MaxLight 490)
Ask
View Details MBS6402666-02 5x 0.1 mL
SLC35F5 (Solute Carrier Family 35 Member F5, Hepatitis C Virus NS5A-transactivated Protein 3, HCV NS5A-transactivated Protein 3, NS5ATP3, UNQ2545/PRO6097) (MaxLight 490)
Ask
View Details